Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Oct;208(4):484-92.
doi: 10.1097/00000658-198810000-00010.

Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients

Affiliations

Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients

D N Herndon et al. Ann Surg. 1988 Oct.

Abstract

Hypermetabolism, increased heart rate, and lipolysis are responses to high catecholamine levels associated with burn injury. This study tests the hypothesis that adrenergic beta blockade in burns could reduce myocardial work, lipolysis, and negative nitrogen balance without adversely affecting cardiac or metabolic function. Eighteen patients with burns of 70 +/- 3% total burn surface area (TBSA) (Mean +/- SEM), were studied after a 5-day infusion of 2 mg/Kg of intravenous (I.V.) propranolol infusion every 24 hours without their cardiac output or resting energy expenditure being adversely reduced. Heart rate, left ventricular work, and rate pressure product were significantly reduced by 20, 22, and 36%, respectively (P less than 0.05). Plasma glucose, free fatty acids, triglycerides, and insulin levels remained unchanged. The rate of urea production, however, was significantly increased by 54 +/- 12% in fasted patients, and to a much lesser 12 +/- 2% in fed patients. The marked decrease in myocardial work afforded by propranolol administration may be of clinical benefit in the treatment of large burns. Variations in drug dosage and feeding regimens will, however, need to be perfected to limit catabolic effects.

PubMed Disclaimer

References

    1. JAMA. 1970 Mar 30;211(13):2130-4 - PubMed
    1. Ann Surg. 1957 Apr;145(4):479-87 - PubMed
    1. J Biol Chem. 1976 Feb 10;251(3):851-7 - PubMed
    1. J Surg Res. 1978 Nov;25(5):394-403 - PubMed
    1. Surg Forum. 1977;28:37-9 - PubMed

MeSH terms